D9F-31398-18371
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 925 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-16
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-23
Health check-in — day 7, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-30
-
2021-05-07
Survey response — day 21, dose 2MedDRA: Arthralgia, Chronic inflammatory response syndrome, Erythema, Feeling hot, Joint swelling, Joint warmth, Pre-existing disease, Psoriasis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Hot, swollen, red, painful joints--began 5/5/21. Could be due to one or more of my chronic inflammatory/autoimmune health conditions. Increased number, size, and severity of psoriasis plaques--began 5/5/21; no known precipitating factors.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Survey response — day 28, dose 2MedDRA: Nausea, Pyrexia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe nausea; intermittent, low-grade feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-21
-
2021-05-28
Survey response — day 42, dose 2MedDRA: Nausea, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Nausea, which could easily be explained by my other medical conditionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-16
Survey response — 3 months, dose 2MedDRA: Arthritis, Candida infection, Nausea, Overgrowth fungal — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Thrush and systemic yeast overgrowth. Increased nausea. Worsening inflammation in joints.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-25
- 2021-10-17
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MigrainesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — day 21, dose 2
Symptoms: Hot, swollen, red, painful joints--began 5/5/21. Could be due to one or more of my chronic inflammatory/autoimmune health conditions. Increased number, size, and severity of psoriasis plaques--began 5/5/21; no known precipitating factors.
Release 8 — day 28, dose 2
Symptoms: Severe nausea; intermittent, low-grade fever
Release 8 — day 42, dose 2
Symptoms: Nausea, which could easily be explained by my other medical conditions
Release 9 — 3 months, dose 2
Symptoms: Thrush and systemic yeast overgrowth. Increased nausea. Worsening inflammation in joints.
Release 11 — 12 months, dose 2
Symptoms: Migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Arthritis | ✓ | · | ✓ |
| SD | Candida infection | ✓ | · | ✓ |
| SD | Chronic inflammatory response syndrome | ○ | ✓ | ○ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Feeling hot | ○ | ✓ | ○ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Joint warmth | ✓ | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Overgrowth fungal | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Psoriasis | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release